PubMed Health⌕ Search

PubMed · 8998821

[The revised European Code Against Malignant Tumors].

Abstract

The European Code Against Cancer is a set of ten recommendations which, if followed, can be the best measure that an individual can take to avoid developing and dying from cancer. Primary and secondary prevention are considered as an important part of cancer control if their use is rational, based on scientific evidence. Six recommendations have to do with primary prevention (smoking, alcohol, diet, overweight, sun exposure, industrial carcinogens), two with secondary prevention, preferably consisting in organized screening programmes (uterine cervix, breast), and two with early diagnosis based on initial symptoms. Considering that smoking is the most important single cause of cancer in Europe tobacco control should be a priority. It is never too late to stop smoking: stopping even in middle age, prior to the onset of tobacco related illness, has a beneficial effect on life expectancy. If the entire population of Europe were to follow these guidelines a minimum of 40% reduction in cancer incidence and an even greater decrease in mortality could be achieved. The revised recommendations are the result of an agreement following 6-year experience of initially practising the original rules, comments and views of cancer experts throughout Europe; they were approved by the European Community Cancer Experts at their meeting in Bonn on 28-29 November 1994. Comprehension and implementation of these principles is of importance both for medical professionals and the general population of all European countries, in particular for members and candidates of the European Union, including the Czech Republic.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

P Boyle, A Kubík. 1996-11-20. [The revised European Code Against Malignant Tumors].. https://pubmed.ncbi.nlm.nih.gov/8998821/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Recurrence risk to offspring in extended multiplex schizophrenia pedigrees from a Pacific Island isolate.

Genetic transmission plays a major role in the pathogenesis of schizophrenia. Family, twin, and adoption studies have consistently shown that risks in relatives are many times greater than the general population risk of approximately 1%. McGue, Gottesman, and Rao (1983; Am J Hum Genet 35:1161-1178) calculated risk estimates of 12.8% for offspring and 3.5% for nieces/nephews of schizophrenia patients based on a large data set of Western European families. The present study evaluated corresponding risk levels in Palau, an isolated population in Micronesia where the prevalence of narrowly (broadly) defined schizophrenia is 1.99% (2.67%) and cases cluster in extended pedigrees, 20 of which contain 80% of affected individuals. We hypothesized that offspring in these extended families would have a higher risk for schizophrenia than offspring in smaller schizophrenia pedigrees from more genetically heterogeneous populations. RDC diagnostic data based on complete ascertainment of cases and their families covering the past two generations were used to quantify empirical recurrence risks in the offspring and nieces/nephews of Palauan schizophrenia patients. Risks to 1st- and 2nd-degree offspring were approximately double the rates found in the smaller Western European families: 23.4% in the offspring of an affected parent, 6.4% in offspring with one affected aunt/uncle, and 15.0% in offspring with two or more affected aunts/uncles. Recurrence rates in offspring of an affected parent were 1.6 times higher in males (27.9%) than in females (17.7%). The high risk levels we found in Palauan offspring reflect the elevated population prevalence, strong familial aggregation, and multi-lineal transmission pattern of schizophrenia in Palau.

Europe↗